青光眼神经保护的临床试验并非不可能。
Clinical trials for glaucoma neuroprotection are not impossible.
机构信息
Glaucoma Services and Dana Center for Preventive Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Curr Opin Ophthalmol. 2012 Mar;23(2):144-54. doi: 10.1097/ICU.0b013e32834ff490.
PMID:22249238
Abstract
PURPOSE OF REVIEW
To discuss issues that affect development of new glaucoma treatments known as neuroprotection.
RECENT FINDINGS
There are barriers to neuroprotection trials for glaucoma.
SUMMARY
With design features discussed in the review, neuroprotection trials can be effectively carried out.
摘要
目的综述
讨论影响新的青光眼治疗方法——神经保护的发展的问题。
最近的发现
神经保护治疗青光眼存在障碍。
总结
通过本文讨论的设计特点，可以有效地进行神经保护试验。
Zotero 插件